Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 701–800 of 1,016
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, A. K., Banerjee, B., Hande, M. P., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.218 · Cited by 62
“In several studies using human diploid cells, activation of Chk1 and Chk2 was proposed to be important for oncogene-induced and replicative senescence (d’Adda di Fagagna et al, 2003; Bartkova et al, 2006; Di Micco et al, 2006; Mallette et al, 2007).”
BackgroundMethodResultRegulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2011) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 53
Tanaka, H., Goto, H., Inoko, A., Makihara, H., Enomoto, A., Horimoto, K., Matsuyama, M., Kurita, K., Izawa, I., & Inagaki, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633891 · Cited by 60
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 71
“Similarly, oncogenic activation engages the DDR by driving hyper-replication, resulting in improperly terminated replication forks and DNA double-strand breaks (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundOncogenic transformation and experimental models of human cancer
Anna, C. S. (2007) · Frontiers in bioscience · doi:10.2741/2661 · Cited by 63
“More recently, senescence has been attributed to cell physiologic insults, such as oxidative stress and DNA damage (28-30), suggesting that senescence serves as a general mechanism to suppress malignant transformation (27, 31, 32).”
BackgroundDNA double-strand break repair and development
Phillips, E. R., & McKinnon, P. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210877 · Cited by 64
“The DNA damage response is also a barrier to transformation, and if inactive in the face of replication stress, cellular transformation can occur (Bartkova et al., 2005, 2006; Braig et al., 2005; Di Micco et al., 2006).”
BackgroundSelenoprotein H Suppresses Cellular Senescence through Genome Maintenance and Redox Regulation
Wu, R. T. Y., Cao, L., Chen, B. P. C., & Cheng, W.-H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611970 · Cited by 55
Brambati, A., Colosio, A., Zardoni, L., Galanti, L., & Liberi, G. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00166 · Cited by 47
Protective role of vitamin D signaling in skin cancer formation
Bikle, D. D., Elalieh, H., Welsh, J., Oh, D., Cleaver, J., & Teichert, A. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.09.021 · Cited by 55
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernández Rodríguez, R., Finnerty, P. M., Ruoff, R., Bardeesy, N., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 54
Ting, H., Yasmin‐Karim, S., Yan, S., Hsu, J., Lin, T., Zeng, W., Messing, J., Sheu, T.-J., Bao, B., Li, W. X., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0042 · Cited by 59
“Recent findings discovered that the DDR signaling cascades ATM/Chk2/p53 pathway is upregulated by oncogenic stress, and inhibition of ATM leads to large and invasive tumor development (23, 24).”
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Benedict, B., van Harn, T., Dekker, M., Hermsen, S., Kucukosmanoglu, A., Pieters, W., Delzenne-Goette, E., Dorsman, J. C., Petermann, E., Foijer, F., et al. (2018) · eLife · doi:10.7554/elife.37868 · Cited by 53
Ohtani, N. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz055 · Cited by 57
Yang, D., Liu, L., & Zheng, X. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.02.001 · Cited by 57
Li, B., Hou, D., Guo, H., Zhou, H., Zhang, S., Xu, X., Liu, Q., Zhang, X., Zou, Y., Gong, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00315-4 · Cited by 54
Restored immune cell functions upon clearance of senescence in the irradiated splenic environment
Palacio, L., Goyer, M., Maggiorani, D., Espinosa, A., Villeneuve, N., Bourbonnais, S., Moquin‐Beaudry, G., Le, O., Demaria, M., Davalos, A. R., et al. (2019) · Aging Cell · doi:10.1111/acel.12971 · Cited by 54
“Senescent cells appear during chronological aging, aberrant oncogene expression, and exposure to DNA damaging agents (Bartkova et al., 2006; Chen, Fischer, Reagan, Yan, & Ames, 1995).”
BackgroundMolecular markers in the surgical margin of oral carcinomas
Bilde, A., von Buchwald, C., Dabelsteen, E., Therkildsen, M. H., & Dabelsteen, S. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00715.x · Cited by 54
Nelson, D. M., McBryan, T., Jeyapalan, J. C., Sedivy, J. M., & Adams, P. D. (2014) · AGE · doi:10.1007/s11357-014-9637-0 · Cited by 64
“Both RS and OIS are thought to act as tumor suppression mechanisms (Braig et al. 2005; Michaloglou et al. 2005; Chen et al. 2005; Bartkova et al. 2006; Feldser and Greider 2007; Cosme-Blanco et al. 2007; Collado et al. 2005).”
BackgroundExcess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency
Ceccon, M., Merlo, M. E. B., Mologni, L., Poggio, T., Varesio, L. M., Menotti, M., Bombelli, S., Rigolio, R., Manazza, A. D., Giacomo, F. D., et al. (2015) · Oncogene · doi:10.1038/onc.2015.456 · Cited by 60
miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways
Su, W., Hong, L., Xu, X., HUANG, S. H., Herpai, D., Li, L., Xu, Y., Truong, L. N., Hu, W.-Y., Wu, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0358-1 · Cited by 57
Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA
d’Alcontres, M. S., Méndez-Bermúdez, A., Foxon, J. L., Royle, N. J., & Salomoni, P. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703020 · Cited by 68
Hongo, A., Okumura, N., Nakahara, M., Kay, E. P., & Koizumi, N. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-21170 · Cited by 53
Rôle de la transition épithélio-mésenchymateuse au cours de la progression tumorale
Puisieux, A. (2009) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32376-3 · Cited by 53
Kossatz-Boehlert, U., Breuhahn, K., Wolf, B., Hardtke‐Wolenski, M., Wilkens, L., Steinemann, D., Singer, S., Brass, F., Kubicka, S., Schlegelberger, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41959 · Cited by 53
Sadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
“In all conditions, genotoxic stress or DNA damage response (DDR) is involved in senescence (Bartkova et al., 2006; Di Micco et al., 2006; Davoli et al., 2010; Jun and Lau, 2010; Chuprin et al., 2013; López-Otín et al., 2013).”
BackgroundA TRF1-controlled common fragile site containing interstitial telomeric sequences
Bosco, N., & de Lange, T. (2012) · Chromosoma · doi:10.1007/s00412-012-0377-6 · Cited by 58
“…precancerous lesions, aberrant stimulation of cell proliferation can induce DNA replication stress that preferentially targets common fragile sites (Bartkova et al. 2006; Gorgoulis et al. 2005; Di Micco et al. 2006; Tsantoulis et al. 2008; Bignell et al. 2010; Dereli-Oz et al. 2011; Bester et al.…”
Snaps and mends: DNA breaks and chromosomal translocations
Javadekar, S. M., & Raghavan, S. C. (2015) · FEBS Journal · doi:10.1111/febs.13311 · Cited by 55
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
Self-citationUnderappreciated Roles of DNA Polymerase δ in Replication Stress Survival
Fuchs, J., Cheblal, A., & Gasser, S. M. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.12.003 · Cited by 54
Bartkova, J., Rajpert‐De Meyts, E., Skakkebæk, N. E., Lukas, J., & Bartek, J. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00772.x · Cited by 53
Kilbey, A., Blyth, K., Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E. R., & Neil, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3016 · Cited by 51
Lee, J. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102808 · Cited by 57
Sfikas, A., Batsi, C., Tselikou, E., Vartholomatos, G., Monokrousos, N., Pappas, P., Christoforidis, S., Tzavaras, T., Kanavaros, P., Gorgoulis, V. G., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.06.010 · Cited by 55
Self-citationSenescence: the good the bad and the dysfunctional
Pazolli, E., & Stewart, S. A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.002 · Cited by 60
“In addition to SAHFs, senescent cells display senescent associated DNA damage foci (SDF) typified by the presence of DNA damage proteins such as 53BP1 and gH2AX [6,7 ,8,9,10 ,11].”
BackgroundQuantitative digital in situ senescence-associated β-galactosidase assay
Shlush, L. I., Itzkovitz, S., Cohen, A., Rutenberg, A., Berkovitz, R., Yehezkel, S., Shahar, H., Selig, S., & Skorecki, K. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-16 · Cited by 49
“Other well studied forms of CS include oncogene-induced senescence [6-8], cell structure induced senescence related to dysfunctional Lamin A [9], and stress-induced premature senescence (SIPS), the latter most thoroughly studied in relation to oxidative stress [10-12].”
BackgroundSignificance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 68
Lin, T.-Y., Cheng, Y.-C., Yang, H.-C., Lin, W.-C., Wang, C.-C., Lai, P.-L., & Shieh, S.-Y. (2011) · Oncogene · doi:10.1038/onc.2011.491 · Cited by 56
“In support of this notion, senescence and senescence-associated secretion have been observed in precancerous lesions (Chen et al., 2005; Bartkova et al., 2006; Majumder et al., 2008) and, in some cases, are accompanied by activation of DNA-damage signaling (Bartkova et al., 2005, 2006; Di Micco et…”
BackgroundInfluentialVerschuren, E. W., Ban, K. H.-K., Masek, M. A., Lehman, N. L., & Jackson, P. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00908-07 · Cited by 52
“These findings are in accordance with recent reports showing a correlation between oncogene-induced senescence in early tumors and a DNA hyperreplication response (3, 13).”
BackgroundResultSample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types
Gundem, G., & López-Bigas, N. (2012) · Genome Medicine · doi:10.1186/gm327 · Cited by 56
“Senescence is an important tumor suppressive barrier to the progression of cancer [37-41].”
BackgroundInterplay Between DNA Tumor Viruses and the Host DNA Damage Response
McFadden, K., & Luftig, M. A. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_9 · Cited by 54
The role of pre‐replicative complex (pre‐RC) components in oncogenesis
Lau, E. K., Tsuji, T., Guo, L., Lu, S., & Jiang, W. B. (2007) · The FASEB Journal · doi:10.1096/fj.07-8900rev · Cited by 58
PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites
Mortusewicz, O., Evers, B., & Helleday, T. (2015) · Oncogene · doi:10.1038/onc.2015.135 · Cited by 52
Self-citationChromá, K., Mistrík, M., Moudrý, P., Gurský, J., Liptay, M., Strauss, R., Škrott, Z., Vrtěl, R., Bártková, J., Kramara, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.392 · Cited by 53
WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation
Kim, J. J., Lee, S. B., Yi, S. Y., Han, S.-A., Kim, S., Lee, J., Tong, S., Yin, P., Gao, B., Zhang, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.148 · Cited by 58
He, Y., Zhao, Y., Wang, L., Bohrer, L. R., Pan, Y., Wang, L., & Huang, H. (2017) · Oncogene · doi:10.1038/onc.2017.353 · Cited by 53
Vitamin D Receptor, UVR, and Skin Cancer: A Potential Protective Mechanism
Bikle, D. D. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.249 · Cited by 53
“During malignant transformation, a DNA repair “barrier” is abrogated (Bartkova et al., 2005, 2006), DDR becomes less con- 2360 Journal of Investigative Dermatology (2008), Volume 128 Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP et al. (1999) Ultraviolet and ionizing radiation…”
BackgroundMyc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced Senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., Huot, G., & Ferbeyre, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707074200 · Cited by 51
The DNA damage checkpoint: A tale from budding yeast
Pizzul, P., Casari, E., Gnugnoli, M., Rinaldi, C., Corallo, F., & Longhese, M. P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.995163 · Cited by 59
Association of RB/p16-Pathway Perturbations with DCIS Recurrence
Witkiewicz, A. K., Rivadeneira, D. B., Ertel, A., Kline, J., Hyslop, T., Schwartz, G. F., Fortina, P. M., & Knudsen, E. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.043 · Cited by 61
Krejčí, P. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.11.001 · Cited by 51
Drosos, Y., Escobar, D., Chiang, M.-Y., Roys, K., Valentine, V. A., Valentine, M. B., Rehg, J. E., Sahai, V., Begley, L., Ye, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11661-8 · Cited by 54
AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11
Piscitello, D., Varshney, D., Lilla, S., Vizioli, M. G., Reid, C., Gorbunova, V. A., Seluanov, A., Gillespie, D. A., & Adams, P. D. (2017) · Oncogene · doi:10.1038/onc.2017.340 · Cited by 54
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective
Cifaldi, L., Locatelli, F., Marasco, E., Moretta, L., & Pistoia, V. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.10.002 · Cited by 57
Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis
Yang, Y., Gao, Y., Zlatanou, A., Tateishi, S., Yurchenko, V., Rogozin, I. B., & Vaziri, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1456296 · Cited by 53
“Moreover, OIS may be a mechanism for eliminating oncogene-expressing cells and thus serves as a barrier to tumorigenesis [54 – 56].”
InfluentialMatsuno, Y., Atsumi, Y., Shimizu, A., Katayama, K., Fujimori, H., Hyodo, M., Minakawa, Y., Nakatsu, Y., Kaneko, S., Hamamoto, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11760-2 · Cited by 53
Ghorai, A., Mahaddalkar, T., Thorat, R. A., & Dutt, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.023 · Cited by 52
ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication
Forrest, J. C., Paden, C. R., ALLEN, R. D., Collins, J. T., & Speck, S. H. (2007) · Journal of Virology · doi:10.1128/jvi.00111-07 · Cited by 58
“Moreover, as oncogene expression or deregulated expression of cell cycle control proteins, including cyclin E, can trigger p53 activation and cell cycle arrest (6, 20, 39, 43, 59), it is tempting to speculate that, while partially rescuing 73.”
BackgroundCell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D. (2012) · Breast Cancer Research · doi:10.1186/bcr3368 · Cited by 50
“The induction of senescence in epithelial cells constitutes a barrier to malignant transformation [41,42], perhaps through the induction of irreversible cell-cycle arrest in damaged cells at high risk for expansion and malignant progression.”
BackgroundAn mRNA expression-based signature for oncogene-induced replication-stress
Llobet, S. G., Bhattacharya, A., Everts, M., Kok, K., van der Vegt, B., Fehrmann, R. S. N., & van Vugt, M. A. T. M. (2022) · Oncogene · doi:10.1038/s41388-021-02162-0 · Cited by 53
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
“Recent studies have shown that OIS is also mediated by a DDR.(25,26) Whereas normal human cells undergo cellular senescence upon an activated oncogene (H-RasV12), inhibition of DDR abrogates OIS.”
BackgroundInfluentialPituitary senescence: The evolving role of Pttg
Chesnokova, V., & Melmed, S. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.012 · Cited by 53
“…in non-growing benign lesions is triggered by activated oncoproteins like BRAF and RAS (Campisi, 2001, Serrano et al., 1997, Braig et al., 2005, Bartkova et al., 2006) supporting in vitro observations that activation of these pathways leads to an initial burst of proliferation followed by DNA…”
BackgroundAcin, S., Li, Z., Mejia, O., Roop, D. R., El‐Naggar, A. K., & Caulin, C. (2011) · The Journal of Pathology · doi:10.1002/path.2971 · Cited by 49
McAndrew, C. W., Gastwirt, R. F., & Donoghue, D. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7451 · Cited by 55
Failure of cell cleavage induces senescence in tetraploid primary cells
Panopoulos, A., Pacios-Bras, C., Choi, J., Mythili, Y., Sussman, M. A., Fotedar, R., & Margolis, R. L. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0844 · Cited by 52
“In contrast to tetraploidy induced senescence, premature senescence in response to oncogene activation or critically short telomeres is preceded by a period of hyperproliferation and accumulation of DNA damage, accompanied by a robust DNA damage checkpoint response (Takai et al., 2003; Bartkova et al., 2006; Di Micco…”
Impact of Replication Stress in Human Papillomavirus Pathogenesis
Moody, C. A. (2018) · Journal of Virology · doi:10.1128/jvi.01012-17 · Cited by 52
The Role of CDK5 in Tumours and Tumour Microenvironments
Do, P. A., & Lee, C. H. (2020) · Cancers · doi:10.3390/cancers13010101 · Cited by 56
Tu, Z., Zhuang, X., Yao, Y., & Zhang, R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01744-12 · Cited by 54
Zheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J. R., & Sun, P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.013 · Cited by 48
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1929-y · Cited by 52
“Cellular senescence is a delayed stress response involving multiple effector mechanisms such as the DNA damage response (7) and the senescence-associated secretion phenotype (SASP)(8-11).”
BackgroundTargeting the DNA damage response and repair in cancer through nucleotide metabolism
Helleday, T., & Rudd, S. G. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13227 · Cited by 52
Self-citationShaikh, N., Mazzagatti, A., Angelis, S. D., Johnson, S. C., Bakker, B., Spierings, D. C. J., Wardenaar, R., Maniati, E., Wang, J., Boemo, M. A., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02781-0 · Cited by 51
The DNA damage response in viral-induced cellular transformation
Nikitin, P. A., & Luftig, M. A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.612 · Cited by 49
“…characterisation of these pathways, the functional significance of the DDR activation was revealed by genetic studies indicating that ATM and Chk2 were critical tumour suppressors downstream of oncogenes including H-RasV12, Mos, Cdc6, and cyclin E (Bartkova et al, 2006; Di Micco et al, 2006).”
BackgroundThe DNA damage response—Repair or despair?
Ljungman, M. E. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20597 · Cited by 62
“DDR has been proposed to act as a major barrier for tumorigenesis by activating cell cycle checkpoints, apoptosis or senescence as a result of oncogene-induced ‘‘replication stress’’ [Bartkova et al., 2005, 2006; Gorgoulis et al., 2005].”
BackgroundLiontos, M., Niforou, K., Velimezi, G., Vougas, K. N., Evangelou, K., Apostolopoulou, K., Vrtěl, R., Damalas, A. F., Kontovazenitis, P., Kotsinas, A., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081160 · Cited by 53
“This finding along with the high frequency of p53 mutations found in our tumor series (Figure 1A, Table 2B) supports one of the key predictions of our concept that the DDR machinery could act as a driving force selecting for p53 mutations at some time during the development of this malignancy.(20,23,39,40,63) Moreover…”
ResultSelf-citationSpeckle-type POZ protein, SPOP, is involved in the DNA damage response
Zhang, D., Wang, H., Sun, M., Yang, J., Zhang, W., Han, S., & Xu, B. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu022 · Cited by 49
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 53
Protective actions of vitamin D in UVB induced skin cancer
Bikle, D. D. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25251a · Cited by 54
“114,115,117,118 Nucleotide excision repair (NER) is the principal means by which UVR damage is repaired.”
Rieck, S., Zhang, J., Li, Z., Liu, C., Naji, A., Takane, K. K., Fiaschi‐Taesch, N., Stewart, A. F., Kushner, J. A., & Kaestner, K. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1019 · Cited by 55
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Role of genomic instability in human carcinogenesis
Moon, J. J., Lu, A., & Moon, C. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219826031 · Cited by 55
Clothing up DNA for all seasons: Histone chaperones and nucleosome assembly pathways
Rocha, W., & Verreault, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.006 · Cited by 53
p16INK4a protects against dysfunctional telomere–induced ATR-dependent DNA damage responses
Wang, Y., Sharpless, N., & Chang, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69574 · Cited by 48
Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
Martínez‐Zamudio, R. I., Stefa, A., de Freitas, J. A. N. L. F., Vasilopoulos, T., Simpson, M., Doré, G. R. G., Roux, P., Galan, M. A., Chokshi, R. J., Bischof, O., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100293 · Cited by 52
Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis
Tho, L. M., Libertini, S., Rampling, R., Sansom, O. J., & Gillespie, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.326 · Cited by 49
“It is now a well-established fact that activated oncogenes can elicit DNA damage and that pre-neoplastic and early-stage neoplastic lesions exhibit evidence of both genotoxic stress and checkpoint activation (”
BackgroundDNA double strand break responses and chromatin alterations within the aging cell
Klement, K., & Goodarzi, A. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.003 · Cited by 53
Mastl kinase, a promising therapeutic target, promotes cancer recurrence
Wang, L., Luong, V. Q., Giannini, P. J., & Peng, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2565 · Cited by 53
López-Vicente, L., Armengol, G., Pons, B., Coch, L., Argelaguet, E., LLeonart, M. E., Hernández‐Losa, J., de Torres, I. M., & y Cajal, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3159 · Cited by 56
Exploring and exploiting the systemic effects of deregulated replication licensing
Petrakis, T. G., Komseli, E.-S., Papaioannou, M. D., Vougas, K., Polyzos, A., Myrianthopoulos, V., Mikros, E., Trougakos, I. P., Thanos, D., Branzei, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.002 · Cited by 52
Self-citationCaveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence
Volonté, D., Vyas, A. R., Chen, C., Đačić, S., Stabile, L. P., Kurland, B. F., Abberbock, S. R., Burns, T. F., Herman, J. G., Di, Y. P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815902 · Cited by 49
Dormant origins and fork protection mechanisms rescue sister forks arrested by transcription
Brambati, A., Zardoni, L., Achar, Y. J., Piccini, D., Galanti, L., Colosio, A., Foiani, M., & Liberi, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx945 · Cited by 50
“The activation of oncogenes promotes replication stress (2,3) that has been proposed to account for the formation of precancerous DNA lesions in early tumorigenesis (1).”
Mouse Models of Accelerated Cellular Senescence
Yousefzadeh, M. J., Melos, K. I., Angelini, L., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Rysanek, D., Vašicová, P., Kolla, J. N., Sedlák, D., Anděra, L., Bártek, J., & Hodný, Z. (2022) · Aging · doi:10.18632/aging.204207 · Cited by 50
“com 11 AGING Cellular senescence induced by activated oncogenes [58, 59] resulting in development of benign preneoplastic lesions (see, e.”
Miyasaka, Y., Nagai, E., Yamaguchi, H., Fujii, K., Inoue, T., Ohuchida, K., Yamada, T., Mizumoto, K., Tanaka, M., & Tsuneyoshi, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0032 · Cited by 51
Chromosomal instability in bladder cancer
Florl, A. R., & Schulz, W. A. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0280-3 · Cited by 58
Bhatia, B., Multani, A. S., Patrawala, L., Chen, X., Calhoun‐Davis, T., Zhou, J., Schroeder, L., Schneider‐Broussard, R., Shen, J., Pathak, S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23222 · Cited by 47
Senescence and the Pro-tumorigenic Stroma
Alspach, E., Fu, Y., & Stewart, S. A. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2014010630 · Cited by 47
Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 50
Bártek, J. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.006 · Cited by 50
Skp2 Regulates G2/M Progression in a p53-dependent Manner
Hu, R., & Aplin, A. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1137 · Cited by 47
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.